BPS Research Committee member and Immediate Past Board Chair, Andrea Iannucci, Pharm.D., BCOP, noted: “It is a distinct pleasure to review all of the proposals and recognize these outstanding researchers. This is a terrific opportunity for BPS to collaborate with others in the pharmacy profession to learn more about the value of BPS board certification.”
BPS Associate Executive Director, Samuel Johnson, Pharm.D., BCPS, stated: “Part of BPS’ mission is to collaborate with researchers seeking to explore the value and impact of board certification on meaningful outcomes, and this year’s proposals clearly embody this viewpoint.”
BPS proudly announces the 2019 grantees:
- Sheila Wang, Pharm.D., BCPS and Justin Moore, Pharm.D., from the Midwestern – Chicago College of Pharmacy and Northwestern Memorial Hospital in Chicago, IL.
- Angela Bingham, Pharm.D., BCPS, BCNSP, BCCCP, and Volodymyra Fedkiv, Pharm.D., from the University of the Sciences, School of Pharmacy in Philadelphia, PA.
The proposal submitted by Drs. Wang and Moore is titled: “Assessment of patients’ perceptions on antimicrobial stewardship and attitudes towards board certified clinical pharmacists within the movement to reduce antimicrobial resistance.”
In their proposal they wrote: “Current antimicrobial stewardship practices emphasize interventions targeted at healthcare clinicians during diagnosis and prescribing. Governing bodies and medical literature support and require institutional antimicrobial stewardship programs to reduce inappropriate antibiotic use to prevent resistance. This approach does not include the patient in shared decision-making, which has been identified as a potential area to improve stewardship. The purpose of this project will be to evaluate patients’ perception and attitudes towards antibiotic use, antimicrobial stewardship, and the value of a board-certified clinical pharmacist to optimize stewardship practices.”
The proposal submitted by Drs. Bingham and Fedkiv is titled: “Prevalence and Value of Board Certification Among Pharmacy Practice Faculty at Colleges and Schools of Pharmacy in the United States.”
In their proposal they wrote: “In 2011, the prevalence of board-certified pharmacy practice faculty in the United States was 37%, but the number of the Board of Pharmacy Specialties (BPS) specialties has increased significantly since that time. The prevalence of BPS certification among pharmacy practice faculty is currently unknown. In addition, limited data exists on the value of BPS certification, as it relates to professional achievements/accomplishments and career advancement, among pharmacy practice faculty in the United States. Our objective is to determine the prevalence of board certification among pharmacy practice faculty in the United States and to describe the motivators and barriers to board certification as well as professional achievements/accomplishments that may support career advancement for pharmacy practice faculty by faculty rank and certification status.”
About the Board of Pharmacy Specialties
The Board of Pharmacy Specialties (BPS) was established in 1976 as an autonomous division of the American Pharmacists Association (APhA). The mission of BPS is to improve patient care by positioning BPS Board-Certified Pharmacist Specialists as integral members of multidisciplinary healthcare teams, through recognition and promotion of specialized training, knowledge, and skills for pharmacists in the United States and internationally. Board certification is a recognized credential for determining which pharmacists are qualified to contribute at advanced practice levels given the rigorous standards mandated by BPS board certification and recertification. BPS currently recognizes more than 42,000 pharmacist certifications across 11 specialties.
Social Media & Content Marketing Manager